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Background: The emergence of multidrug resistant Pseudomonas aeruginosa (MDRPA) as one 
of the leading nosocomial pathogens imposes a serious health threat due to limited antibiotic 
options. In this study, a sample of clonally distinct MDRPA and sensitive strains of 
Pseudomonas 
aeruginosa (SSPA) were tested against various antibiotics combinations to establish synergistic 
activity against these strains. 
Methods: A total of 39 retrospectively collected MDRPA strains isolated over three years with a 
particular antibiogram (sensitive to colistin but resistant to ceftazidime, cefepime, cefoperazone, 
cefoperazone/sulbactam , ciprofloxacin, imipenem, meropenem, piperacillin, 
piperacillintazobactam, 
gentamicin, netilmicin, with varying susceptibility to amikacin) and 19 SSPA 
collected prospectively were genotyped using Spe1 DNA macrorestriction analysis and 
pulsedfield 
gel electrophoresis (PFGE). The strains were from different patients from various sites 
(blood, tissue, fluid, catheter tip, bronchiol alveolar lavage (BAL), urine, sputum, swab, tracheal 
secretion and nasal swab). Clonal relatedness was determined at �85% level of similarity and 
grouped into different clusters. A representative strain from each cluster was tested against 10 
different paired combinations of various antimicrobials (�-lactams, quinolone, aminoglycoside, 
tigecycline, rifampicin and colistin) to establish synergistic activity against these strains using 
the 
investigational E test fixed ratio method. 
Results: There were 46 distinct clones out of a total of 58 MDRPA and SSPA resolved by PFGE 
from which 10 clonally distinct strains (8 MDRPA and 2 SSPA strains) were selected for 
synergy 
testing. The antibiotic combination which most frequently demonstrated synergy was cefepime 
with amikacin (4/10 strains). Other synergistic combinations were aztreonam with either 
ceftazidime or cefepime, and meropenem with ciprofloxacin (3/10 strains respectively), 
ceftazidime with either ciprofloxacin or amikacin (2/10 strains respectively) and imipenem with 
ciprofloxacin (1/10 strains). The combination of ceftazidime with amikacin was antagonistic in 
1/10 strains. The other antibiotics combinations were either additive or indifferent. 
Conclusion: PFGE was a useful and discriminative molecular subtyping tool to establish clonal 
relatedness among strains. Results of antimicrobial synergy testing indicate that although certain 
combinations may act synergistically, it was still strain dependent. These preliminary findings 
require further confirmation with testing of a larger number of isolates. 
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